Drug
Nerve Growth Factor clinical trials
Also written NGF.
- studies test it
- 10
- open now
- 1
- in phase 3
- 1
- first study started
- 2008
Keep track of what changes. Save the Nerve Growth Factor studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Other names
- NGF
- 4
Studies by the year they started
10 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2022 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 3
- Phase 1
- 1
- Phase 2
- 4
- Phase 3
- 1
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 8
Aalborg University (3) · Dompé Farmaceutici S.p.A (1) · Jinling Hospital, China (1) · Prof Herta Flor (1) · Beijing Tiantan Hospital (1) · The Third Affiliated hospital of Zhejiang Chinese Medical University (1) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1) · NsGene A/S (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Nerve Growth Factor is read from its arms, and is right about nine times in ten.
Testing it · 10
- Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules in the Treatment of Amyotrophic Lateral SclerosisNot yet recruitingPhase 2/3Beijing Tiantan HospitalNCT06391645Written as Nerve Growth Factor
- Effect of EA Combined With NGF on Limb Function in Convalescent Patients With Ischemic StrokeStatus unknownNot applicableThe Third Affiliated hospital of Zhejiang Chinese Medical UniversityNCT05652751Written as nerve growth factor
- Efficacy and Safety of Nerve Growth Factor or Edaravone on Alcohol-induced Brain InjuryStatus unknownPhase 2Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNCT03968042Written as Nerve Growth Factor
- Exercise-induced Ischemia and the Influence of Pain Modulation in a Nerve Growth Factor (NGF) ModelStatus unknownEarly Phase 1Aalborg UniversityNCT03844243Written as NGF
- Interaction Between NGF and Acute Exercise-induced IschemiaCompletedEarly Phase 1Aalborg UniversityNCT03470038Written as NGF
- An 8-week Study to Evaluate Safety and Efficacy of NGF Eye Drops Solution Versus Vehicle in Patients With Dry EyeCompletedPhase 2Dompé Farmaceutici S.p.ANCT03019627Written as NGF
- Spread of Muscle Hyperalgesia and Pain in a Low Dose NGF-induced Pain ModelCompletedEarly Phase 1Aalborg UniversityNCT03217942Written as NGF
- Effects of Intranasal Nerve Growth Factor for Traumatic Brain InjuryCompletedPhase 2Jinling Hospital, ChinaNCT01212679Written as nerve growth factor
- Cortical Representation of Hyperalgesia Induced by Nerve Growth FactorCompletedNot applicableProf Herta FlorNCT02159170Written as NGF injection
- Encapsulated Cell Biodelivery of Nerve Growth Factor to Alzheimer´s Disease PatientsStatus unknownPhase 1NsGene A/SNCT01163825Written as Nerve Growth Factor
Codes
What other systems call Nerve Growth Factor · ClinicalTrials.gg INT008784
- MeSH (NLM) D020932Nerve Growth FactorOne source Wikidata
- UNII (FDA) V7FWP1D62ONERVE GROWTH FACTORConfirmed FDA, Wikidata
- RxNorm 7327One source FDA
- Wikidata Q417782nerve growth factorConfirmed FDA, Wikidata
- NCI Thesaurus C684Recombinant Nerve Growth FactorOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D020932 | Nerve Growth Factor | One source Wikidata |
| UNII (FDA) | V7FWP1D62O | NERVE GROWTH FACTOR | Confirmed FDA, Wikidata |
| RxNorm | 7327 | — | One source FDA |
| Wikidata | Q417782 | nerve growth factor | Confirmed FDA, Wikidata |
| NCI Thesaurus | C684 | Recombinant Nerve Growth Factor | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.